Mobile Menu

Search Results

Search results for: safety

The impact of COVID-19 on the rare disease community

For the last few weeks, we have been covering COVID-related stories, from the sequencing of the virus, the research efforts, […]

The potential role of PGx in managing experimental therapies for COVID-19

Since the outbreak of the COVID-19 pandemic, many clinical trials have been launched to help understand the virus and any […]

Terms and Conditions

Terms and Conditions We’ve tried our best to make sure everything in our terms and conditions is as clear as […]

Gene therapy: The what, the how and the ethics

What is gene therapy? Given the hype around gene therapy and the recent approvals for use, everyone has heard or […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

New diagnostic for Coronavirus receives CE mark

Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.

Interview with Dr Rona Strawbridge, UKRI Innovation

Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.